Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Erdosteine in Pulmonary Disease, Chronic Obstructive: CTRI/2026/05/110935 Clinical Landscape Report 2026
9 min read
Erdosteine in Pulmonary Disease, Chronic Obstructive: CTRI/2026/05/110935 Clinical Landscape Report 2026
28 September 2026
CTRI/2026/05/110935 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and developm…
Read →
Leucovorin Calcium in Locally Advanced Cholangiocarcinoma: NCT07619313 Clinical Landscape Report 2026
9 min read
Leucovorin Calcium in Locally Advanced Cholangiocarcinoma: NCT07619313 Clinical Landscape Report 2026
28 September 2026
NCT07619313 clinical landscape for Locally Advanced Cholangiocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
Read →
LT-010391 in Pancreatic Ductal Adenocarcinoma: NCT07624214 Clinical Landscape Report 2026
9 min read
LT-010391 in Pancreatic Ductal Adenocarcinoma: NCT07624214 Clinical Landscape Report 2026
28 September 2026
NCT07624214 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
Mirikizumab in Inflammatory Bowel Diseases: NCT07612267 Clinical Landscape Report 2026
9 min read
Mirikizumab in Inflammatory Bowel Diseases: NCT07612267 Clinical Landscape Report 2026
28 September 2026
NCT07612267 clinical landscape for Inflammatory Bowel Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
64Cu-DOTA-A2DM in Pancreatic adenocarcinoma metastatic: NCT07608627 Clinical Landscape Report 2026
9 min read
64Cu-DOTA-A2DM in Pancreatic adenocarcinoma metastatic: NCT07608627 Clinical Landscape Report 2026
28 September 2026
NCT07608627 clinical landscape for Pancreatic adenocarcinoma metastatic: endpoints, sponsor, phase, geography, readouts, asset context and development white…
Read →
MTX-325 in Young onset Parkinson disease: NCT07630545 Clinical Landscape Report 2026
9 min read
MTX-325 in Young onset Parkinson disease: NCT07630545 Clinical Landscape Report 2026
28 September 2026
NCT07630545 clinical landscape for Young onset Parkinson disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
QLF-4113 in Metastatic Prostate Carcinoma: NCT07636707 Clinical Landscape Report 2026
9 min read
QLF-4113 in Metastatic Prostate Carcinoma: NCT07636707 Clinical Landscape Report 2026
28 September 2026
NCT07636707 clinical landscape for Metastatic Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
IBI-363 in Hepatocellular Carcinoma: NCT07644208 Clinical Landscape Report 2026
9 min read
IBI-363 in Hepatocellular Carcinoma: NCT07644208 Clinical Landscape Report 2026
28 September 2026
NCT07644208 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Abiraterone acetate in Male Genital Neoplasms: CTRI/2026/06/112300 Clinical Landscape Report 2026
9 min read
Abiraterone acetate in Male Genital Neoplasms: CTRI/2026/06/112300 Clinical Landscape Report 2026
28 September 2026
CTRI/2026/06/112300 clinical landscape for Male Genital Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Fludarabine Phosphate in Metastatic castration-resistant prostate cancer: NCT07641049 Clinical Landscape Report 2026
9 min read
Fludarabine Phosphate in Metastatic castration-resistant prostate cancer: NCT07641049 Clinical Landscape Report 2026
28 September 2026
NCT07641049 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
Read →
Allopurinol in Musculoskeletal Diseases: ACTRN12626000741381 Clinical Landscape Report 2026
9 min read
Allopurinol in Musculoskeletal Diseases: ACTRN12626000741381 Clinical Landscape Report 2026
28 September 2026
ACTRN12626000741381 clinical landscape for Musculoskeletal Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
Coated Aldehyde Oxystarch in Kidney Failure, Chronic: NCT07653711 Clinical Landscape Report 2026
9 min read
Coated Aldehyde Oxystarch in Kidney Failure, Chronic: NCT07653711 Clinical Landscape Report 2026
28 September 2026
NCT07653711 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →